Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-07-31 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: WOINCOURT (80520), Somme
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DUMESNIL : revenue, balance sheet and financial ratios
PHARMACIE DUMESNIL is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in WOINCOURT (80520),
this company of category PME
shows in 2024 a net income positive of 192 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DUMESNIL (SIREN 841493844)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
191 635 €
104 623 €
155 513 €
159 421 €
124 321 €
39 812 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DUMESNIL generates positive net income of 192 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 40 k€ -> 192 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
191 635 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 135%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
134.679%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
34.508%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
764.319
373.024
235.895
167.921
203.263
134.679
Financial autonomy
10.217
18.193
25.697
32.09
27.118
34.508
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
134.682024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of PHARMACIE DUMESNIL (134.68) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
34.51%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average
In 2024, the financial autonomy of PHARMACIE DUMESNIL (34.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 190.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
190.98
Liquidity indicators evolution PHARMACIE DUMESNIL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
170.69
173.65
190.508
198.447
183.121
190.98
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
190.982024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good
In 2024, the liquidity ratio of PHARMACIE DUMESNIL (190.98) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DUMESNIL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DUMESNIL is estimated at
2 675 366 €
(range 1 863 082€ - 4 002 501€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1863k€2675k€4002k€
2 675 366 €Range: 1 863 082€ - 4 002 501€
NAF 5 année 2024
Valuation method used
Net Income Multiple
191 635 €
×
14.0x
=2 675 366 €
Range: 1 863 083€ - 4 002 501€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DUMESNIL with other companies in the same sector:
Frequently asked questions about PHARMACIE DUMESNIL
What is the revenue of PHARMACIE DUMESNIL ?
The revenue of PHARMACIE DUMESNIL is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DUMESNIL profitable?
Yes, PHARMACIE DUMESNIL generated a net profit of 192 k€ in 2024.
Where is the headquarters of PHARMACIE DUMESNIL ?
The headquarters of PHARMACIE DUMESNIL is located in WOINCOURT (80520), in the department Somme.
Where to find the tax return of PHARMACIE DUMESNIL ?
The tax return of PHARMACIE DUMESNIL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DUMESNIL operate?
PHARMACIE DUMESNIL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart